United States (US) Geographic Atrophy Market (2025-2031) | Segmentation, Trends, Analysis, Value, Share, Forecast, Growth, Competitive Landscape, Size & Revenue, Companies, Outlook, Industry

Name: United States (US) Geographic Atrophy Market (2025-2031) | Trends & Outlook
Creator: 6Wresearch
License: https://www.6wresearch.com/privacy-policy

Market Forecast By Age Group (Above 60 Years, Above 75 Years), By Diagnosis (Fundus Autofluorescence (FAF), Optical Coherence Tomography Angiography (OCT-A), Multifocal Electroretinography (MfERG)), By Therapeutic Agents Clinical Phase (Late-Stage (Phase III), Phase II, Phase I) And Competitive Landscape

Product Code: ETC9966903	Publication Date: Sep 2024	Updated Date: Aug 2025	Product Type: Market Research Report
Publisher: 6Wresearch	Author: Dhaval Chaurasia	No. of Pages: 75	No. of Figures: 35	No. of Tables: 20

Key Highlights of the Report:

United States (US) Geographic Atrophy Market Outlook
Market Size of United States (US) Geographic Atrophy Market, 2024
Forecast of United States (US) Geographic Atrophy Market, 2031
Historical Data and Forecast of United States (US) Geographic Atrophy Revenues & Volume for the Period 2021- 2031
United States (US) Geographic Atrophy Market Trend Evolution
United States (US) Geographic Atrophy Market Drivers and Challenges
United States (US) Geographic Atrophy Price Trends
United States (US) Geographic Atrophy Porter's Five Forces
United States (US) Geographic Atrophy Industry Life Cycle
Historical Data and Forecast of United States (US) Geographic Atrophy Market Revenues & Volume By Age Group for the Period 2021- 2031
Historical Data and Forecast of United States (US) Geographic Atrophy Market Revenues & Volume By Above 60 Years for the Period 2021- 2031
Historical Data and Forecast of United States (US) Geographic Atrophy Market Revenues & Volume By Above 75 Years for the Period 2021- 2031
Historical Data and Forecast of United States (US) Geographic Atrophy Market Revenues & Volume By Diagnosis for the Period 2021- 2031
Historical Data and Forecast of United States (US) Geographic Atrophy Market Revenues & Volume By Fundus Autofluorescence (FAF) for the Period 2021- 2031
Historical Data and Forecast of United States (US) Geographic Atrophy Market Revenues & Volume By Optical Coherence Tomography Angiography (OCT-A) for the Period 2021- 2031
Historical Data and Forecast of United States (US) Geographic Atrophy Market Revenues & Volume By Multifocal Electroretinography (MfERG) for the Period 2021- 2031
Historical Data and Forecast of United States (US) Geographic Atrophy Market Revenues & Volume By Therapeutic Agents Clinical Phase for the Period 2021- 2031
Historical Data and Forecast of United States (US) Geographic Atrophy Market Revenues & Volume By Late-Stage (Phase III) for the Period 2021- 2031
Historical Data and Forecast of United States (US) Geographic Atrophy Market Revenues & Volume By Phase II for the Period 2021- 2031
Historical Data and Forecast of United States (US) Geographic Atrophy Market Revenues & Volume By Phase I for the Period 2021- 2031
United States (US) Geographic Atrophy Import Export Trade Statistics
Market Opportunity Assessment By Age Group
Market Opportunity Assessment By Diagnosis
Market Opportunity Assessment By Therapeutic Agents Clinical Phase
United States (US) Geographic Atrophy Top Companies Market Share
United States (US) Geographic Atrophy Competitive Benchmarking By Technical and Operational Parameters
United States (US) Geographic Atrophy Company Profiles
United States (US) Geographic Atrophy Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

How does 6Wresearch market report help businesses in making strategic decisions?

Do you also provide customisation in the market study?

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) Geographic Atrophy Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Geographic Atrophy Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Geographic Atrophy Market - Industry Life Cycle

3.4 United States (US) Geographic Atrophy Market - Porter's Five Forces

3.5 United States (US) Geographic Atrophy Market Revenues & Volume Share, By Age Group, 2021 & 2031F

3.6 United States (US) Geographic Atrophy Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F

3.7 United States (US) Geographic Atrophy Market Revenues & Volume Share, By Therapeutic Agents Clinical Phase, 2021 & 2031F

4 United States (US) Geographic Atrophy Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing aging population in the US

4.2.2 Growing prevalence of age-related macular degeneration (AMD)

4.2.3 Technological advancements in diagnostic tools and treatment options

4.3 Market Restraints

4.3.1 High cost of treatment and management of geographic atrophy

4.3.2 Limited awareness among patients and healthcare providers about geographic atrophy

4.3.3 Stringent regulatory requirements for approval of new therapies

5 United States (US) Geographic Atrophy Market Trends

6 United States (US) Geographic Atrophy Market, By Types

6.1 United States (US) Geographic Atrophy Market, By Age Group

6.1.1 Overview and Analysis

6.1.2 United States (US) Geographic Atrophy Market Revenues & Volume, By Age Group, 2021- 2031F

6.1.3 United States (US) Geographic Atrophy Market Revenues & Volume, By Above 60 Years, 2021- 2031F

6.1.4 United States (US) Geographic Atrophy Market Revenues & Volume, By Above 75 Years, 2021- 2031F

6.2 United States (US) Geographic Atrophy Market, By Diagnosis

6.2.1 Overview and Analysis

6.2.2 United States (US) Geographic Atrophy Market Revenues & Volume, By Fundus Autofluorescence (FAF), 2021- 2031F

6.2.3 United States (US) Geographic Atrophy Market Revenues & Volume, By Optical Coherence Tomography Angiography (OCT-A), 2021- 2031F

6.2.4 United States (US) Geographic Atrophy Market Revenues & Volume, By Multifocal Electroretinography (MfERG), 2021- 2031F

6.3 United States (US) Geographic Atrophy Market, By Therapeutic Agents Clinical Phase

6.3.1 Overview and Analysis

6.3.2 United States (US) Geographic Atrophy Market Revenues & Volume, By Late-Stage (Phase III), 2021- 2031F

6.3.3 United States (US) Geographic Atrophy Market Revenues & Volume, By Phase II, 2021- 2031F

6.3.4 United States (US) Geographic Atrophy Market Revenues & Volume, By Phase I, 2021- 2031F

7 United States (US) Geographic Atrophy Market Import-Export Trade Statistics

7.1 United States (US) Geographic Atrophy Market Export to Major Countries

7.2 United States (US) Geographic Atrophy Market Imports from Major Countries

8 United States (US) Geographic Atrophy Market Key Performance Indicators

8.1 Number of patients diagnosed with geographic atrophy annually

8.2 Adoption rate of new diagnostic tools and treatment options

8.3 Research and development investment in geographic atrophy therapies

8.4 Patient outcomes and quality of life improvements

8.5 Number of clinical trials and pipeline therapies for geographic atrophy

9 United States (US) Geographic Atrophy Market - Opportunity Assessment

9.1 United States (US) Geographic Atrophy Market Opportunity Assessment, By Age Group, 2021 & 2031F

9.2 United States (US) Geographic Atrophy Market Opportunity Assessment, By Diagnosis, 2021 & 2031F

9.3 United States (US) Geographic Atrophy Market Opportunity Assessment, By Therapeutic Agents Clinical Phase, 2021 & 2031F

10 United States (US) Geographic Atrophy Market - Competitive Landscape

10.1 United States (US) Geographic Atrophy Market Revenue Share, By Companies, 2024

10.2 United States (US) Geographic Atrophy Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Africa Geographic Atrophy Market

Estonia Geographic Atrophy Market

Ethiopia Geographic Atrophy Market

Fiji Geographic Atrophy Market

Finland Geographic Atrophy Market

Gabon Geographic Atrophy Market

Global Geographic Atrophy Market

Middle East Geographic Atrophy Market

North America Geographic Atrophy Market

Global Go To Market Strategy - 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here